These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28584146)

  • 1. Targeted Metabolomics Analysis Identifies Intestinal Microbiota-Derived Urinary Biomarkers of Colonization Resistance in Antibiotic-Treated Mice.
    Obrenovich ME; Tima M; Polinkovsky A; Zhang R; Emancipator SN; Donskey CJ
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomics analysis identifies intestinal microbiota-derived biomarkers of colonization resistance in clindamycin-treated mice.
    Jump RL; Polinkovsky A; Hurless K; Sitzlar B; Eckart K; Tomas M; Deshpande A; Nerandzic MM; Donskey CJ
    PLoS One; 2014; 9(7):e101267. PubMed ID: 24988418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do piperacillin/tazobactam and other antibiotics with inhibitory activity against Clostridium difficile reduce the risk for acquisition of C. difficile colonization?
    Kundrapu S; Sunkesula VC; Jury LA; Cadnum JL; Nerandzic MM; Musuuza JS; Sethi AK; Donskey CJ
    BMC Infect Dis; 2016 Apr; 16():159. PubMed ID: 27091232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IMPACT OF TIGECYCLINE VERSUS OTHER ANTIBIOTICS ON THE FECAL METABOLOME AND ON COLONIZATION RESISTANCE TO
    Jump RL; Kraft D; Hurless K; Polinkovsky A; Donskey CJ
    Pathog Immun; 2017 Jan; 2(1):1-20. PubMed ID: 28217763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea.
    Wilcox MH; Freeman J; Fawley W; MacKinlay S; Brown A; Donaldson K; Corrado O
    J Antimicrob Chemother; 2004 Jul; 54(1):168-72. PubMed ID: 15163654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota That Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice.
    Tomas ME; Mana TSC; Wilson BM; Nerandzic MM; Joussef-Piña S; Quiñones-Mateu ME; Donskey CJ
    Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29530853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased susceptibility to vancomycin-resistant Enterococcus intestinal colonization persists after completion of anti-anaerobic antibiotic treatment in mice.
    Stiefel U; Pultz NJ; Helfand MS; Donskey CJ
    Infect Control Hosp Epidemiol; 2004 May; 25(5):373-9. PubMed ID: 15188841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifts in the Gut Metabolome and
    Fletcher JR; Erwin S; Lanzas C; Theriot CM
    mSphere; 2018; 3(2):. PubMed ID: 29600278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model.
    Baines SD; Freeman J; Wilcox MH
    J Antimicrob Chemother; 2005 Jun; 55(6):974-82. PubMed ID: 15860551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic-Induced Alterations of the Murine Gut Microbiota and Subsequent Effects on Colonization Resistance against Clostridium difficile.
    Schubert AM; Sinani H; Schloss PD
    mBio; 2015 Jul; 6(4):e00974. PubMed ID: 26173701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Antibiotics and Diet on Enterolactone Concentration and Metabolome Studied by Targeted and Nontargeted LC-MS Metabolomics.
    Bolvig AK; Nørskov NP; Hedemann MS; Foldager L; McCarthy-Sinclair B; Marco ML; Lærke HN; Bach Knudsen KE
    J Proteome Res; 2017 Jun; 16(6):2135-2150. PubMed ID: 28294620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orally administered beta-lactamase enzymes represent a novel strategy to prevent colonization by Clostridium difficile.
    Stiefel U; Nerandzic MM; Koski P; Donskey CJ
    J Antimicrob Chemother; 2008 Nov; 62(5):1105-8. PubMed ID: 18693236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orally administered recombinant metallo-beta-lactamase preserves colonization resistance of piperacillin-tazobactam-treated mice.
    Stiefel U; Harmoinen J; Koski P; Kääriäinen S; Wickstrand N; Lindevall K; Pultz NJ; Bonomo RA; Helfand MS; Donskey CJ
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5190-1. PubMed ID: 16304203
    [No Abstract]   [Full Text] [Related]  

  • 14. Urinary Metabolites of Green Tea as Potential Markers of Colonization Resistance to Pathogenic Gut Bacteria in Mice.
    Obrenovich ME; Jaskiw GE; Mana TSC; Bennett CP; Cadnum J; Donskey CJ
    Pathog Immun; 2019; 4(2):271-293. PubMed ID: 31773068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Analysis of drug resistance of
    Liu S; Wang C; Fu YX
    Zhonghua Shao Shang Za Zhi; 2017 Jul; 33(7):404-409. PubMed ID: 28763905
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro antienterococcal activity explains associations between exposures to antimicrobial agents and risk of colonization by multiresistant enterococci.
    Rice LB; Lakticová V; Helfand MS; Hutton-Thomas R
    J Infect Dis; 2004 Dec; 190(12):2162-6. PubMed ID: 15551215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating effects of penicillin treatment on the metabolome of rats.
    Sun J; Schnackenberg LK; Khare S; Yang X; Greenhaw J; Salminen W; Mendrick DL; Beger RD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Aug; 932():134-43. PubMed ID: 23831706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy.
    Dinubile MJ; Friedland I; Chan CY; Motyl MR; Giezek H; Shivaprakash M; Weinstein RA; Quinn JP
    Eur J Clin Microbiol Infect Dis; 2005 Jul; 24(7):443-9. PubMed ID: 15990986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the risk of acquiring in vitro resistance to doripenem and tazobactam/piperacillin by CTX-M-15-producing Escherichia coli.
    Horiyama T; Kanazawa S; Hara T; Izawa M; Sato T; Yamaguchi T; Tsuji M; Maki H
    J Infect Chemother; 2015 May; 21(5):381-4. PubMed ID: 25662788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice.
    Pultz MJ; Donskey CJ
    Antimicrob Agents Chemother; 2007 Aug; 51(8):3044-5. PubMed ID: 17562802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.